Thus, it abolished FOXO3-medaited activity of promoters of MMP13 and MMP9, prevented binding of the TF to repress LUM expression, and negatively affected the FOXO3-regulated migration of NB cells [53]. The gene discussed is FOXO3; the disease is neuroblastoma.